Calamos Advisors’s Baird Medical Investment Holdings Warrant BDMDW Stock Holding History

Calamos Advisors’s Portfolio BDMDW Stock Details BDMDW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$24.5K	Hold	500,000	–	–	﹤0.01%	948
2026 Q1	$52.5K	Hold	500,000	–	–	﹤0.01%	1147
2025 Q4	$26.4K	Hold	500,000	–	–	﹤0.01%	884
2025 Q3	$36.3K	Hold	500,000	–	–	﹤0.01%	879
2025 Q2	$42.5K	Hold	500,000	–	–	﹤0.01%	864
2025 Q1	$37.5K	Hold	500,000	–	–	﹤0.01%	842
2024 Q4	$103K	Buy	+500,000	New	+$19.8K	﹤0.01%	821

Other funds holding BDMDW

DCM

Dupont Capital Management Wilmington, Delaware $2.18M AUM 50.81% 1-Year Est. Return

Calamos Advisors's BDMDW Position: Q2 2026 in Review

Calamos Advisors held its Baird Medical Investment Holdings Warrant (BDMDW) position steady in Q2 2026 at 500,000 shares worth $24.5K. The position accounts for ﹤0.01% of the portfolio, ranked #948.

Calamos Advisors first reported a position in BDMDW in Q4 2024 and has held it in 7 quarters since. The position peaked at $103K in Q4 2024. 2 funds tracked by Wall St. Rank hold BDMDW as of Q2 2026.

Calamos Advisors held 500,000 shares of Baird Medical Investment Holdings Warrant worth $24.5K as of Q2 2026.
Calamos Advisors left its Baird Medical Investment Holdings Warrant share count unchanged in Q2 2026.
Baird Medical Investment Holdings Warrant made up ﹤0.01% of Calamos Advisors's portfolio in Q2 2026, its #948 holding.
Calamos Advisors first reported a position in Baird Medical Investment Holdings Warrant in Q4 2024 and has held it in 7 quarters since.
Calamos Advisors's Baird Medical Investment Holdings Warrant position peaked at $103K in Q4 2024.
2 funds tracked by Wall St. Rank held Baird Medical Investment Holdings Warrant as of Q2 2026.

Based on Calamos Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.